We are live on ! Find out more
ASMB icon

Assembly Biosciences

24 hedge funds and large institutions have $33.5M invested in Assembly Biosciences in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 3

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

137% more capital invested

Capital invested by funds: $14.1M → $33.5M (+$19.3M)

9% more funds holding

Funds holding: 2224 (+2)

Holders
24
Holders Change
+2
Holders Change %
+9.09%
% of All Funds
0.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
11
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

ASMB Hedge Fund Activity: Q4 2014 in Review

24 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2014, worth a combined $33.5M — up 137% from $14.1M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ASMB positions and 2 closed out — a net gain of 4 holders — while 11 added to existing stakes and 3 trimmed.

The largest buyer was QVT Financial, opening a new position worth an estimated $4.39M. The largest seller was BlackRock Institutional Trust, cutting an estimated $136K.

  • 24 institutional investors held Assembly Biosciences (ASMB) as of Q4 2014, up from 22 in Q3 2014.
  • Funds reported $33.5M of Assembly Biosciences stock for Q4 2014, up 137% quarter-over-quarter.
  • 6 funds opened new Assembly Biosciences positions in Q4 2014 and 2 closed out, a net change of +4 holders.
  • The largest Assembly Biosciences buyer in Q4 2014 was QVT Financial, an estimated $4.39M added.
  • The largest Assembly Biosciences seller in Q4 2014 was BlackRock Institutional Trust, an estimated $136K sold.

Based on aggregated 13F filings for Q4 2014.